Rawcliffe Adrian sold Wave Life Sciences Ltd. ($WVE) shares on the open market twice in the last 365 days, totaling about $739 thousand. His most recent sale occurred on December 8, 2025. These sales rank 5,614th among 11,678 individual insiders by value, below the average of $8.6 million across 6 sales per insider. He made no open market purchases during this period.
| Transaction Date | Company | Ticker | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Dec. 8, 2025 | Wave Life Sciences Ltd. | $WVE | Rawcliffe Adrian | Not found | M | Ordinary Shares | 42000 | $5.97 | 54,700.0000 | 167,739,208 | 330.71% | 0.03% |
| Dec. 8, 2025 | Wave Life Sciences Ltd. | $WVE | Rawcliffe Adrian | Not found | M | Share Option (right to buy) | 42000 | $0.00 | 0.0000 | 167,739,208 | 100.00% | 0.03% |
| Dec. 8, 2025 | Wave Life Sciences Ltd. | $WVE | Rawcliffe Adrian | Not found | S | Ordinary Shares | 42000 | $15.00 | 12,700.0000 | 167,739,208 | 76.78% | 0.03% |
| Nov. 13, 2025 | Wave Life Sciences Ltd. | $WVE | Rawcliffe Adrian | Not found | S | Ordinary Shares | 16115 | $6.79 | 12,700.0000 | 167,739,208 | 55.93% | 0.01% |
| Aug. 11, 2025 | Wave Life Sciences Ltd. | $WVE | Rawcliffe Adrian | Not found | A | Ordinary Shares | 12700 | $0.00 | 28,815.0000 | 138,277,468 | 78.81% | 0.01% |
| Aug. 11, 2025 | Wave Life Sciences Ltd. | $WVE | Rawcliffe Adrian | Not found | A | Share Option (right to buy) | 76200 | $0.00 | 76,200.0000 | 138,277,468 | 9999.99% | 0.06% |
| Feb. 20, 2025 | Adaptimmune Therapeutics PLC | $ADAPY | Rawcliffe Adrian | Chief Executive Officer | A | Option to purchase Ordinary Shares | 3428832 | $0.00 | 3,428,832.0000 | 1,513,810,852 | 9999.99% | 0.23% |
| Feb. 20, 2025 | Adaptimmune Therapeutics PLC | $ADAPY | Rawcliffe Adrian | Chief Executive Officer | A | Option to purchase Ordinary Shares | 5143248 | $0.00 | 5,143,248.0000 | 1,513,810,852 | 9999.99% | 0.34% |
| Jan. 17, 2025 | Adaptimmune Therapeutics PLC | $ADAPY | Rawcliffe Adrian | Chief Executive Officer | S | American Depositary Shares representing Ordinary Shares | 30601 | $0.58 | 44,327.0000 | 1,513,810,852 | 40.84% | 0.00% |
| Jan. 13, 2025 | Adaptimmune Therapeutics PLC | $ADAPY | Rawcliffe Adrian | Chief Executive Officer | S | American Depositary Shares representing Ordinary Shares | 12539 | $0.59 | 17,801.0000 | 1,513,810,852 | 41.33% | 0.00% |
| Jan. 13, 2025 | Adaptimmune Therapeutics PLC | $ADAPY | Rawcliffe Adrian | Chief Executive Officer | S | American Depositary Shares representing Ordinary Shares | 17934 | $0.59 | 25,711.0000 | 1,513,810,852 | 41.09% | 0.00% |
| Jan. 15, 2025 | Adaptimmune Therapeutics PLC | $ADAPY | Rawcliffe Adrian | Chief Executive Officer | S | American Depositary Shares representing Ordinary Shares | 29096 | $0.57 | 41,582.0000 | 1,513,810,852 | 41.17% | 0.00% |
| Aug. 12, 2024 | Wave Life Sciences Ltd. | $WVE | Rawcliffe Adrian | Not found | A | Ordinary Shares | 16115 | $0.00 | 16,115.0000 | 106,097,268 | 9999.99% | 0.02% |
| Aug. 12, 2024 | Wave Life Sciences Ltd. | $WVE | Rawcliffe Adrian | Not found | A | Share Option (right to buy) | 32230 | $0.00 | 32,230.0000 | 106,097,268 | 9999.99% | 0.03% |
| Jan. 15, 2024 | Adaptimmune Therapeutics PLC | $ADAPY | Rawcliffe Adrian | Chief Executive Officer | A | Option to purchase Ordinary Shares | 1696272 | $0.00 | 1,696,272.0000 | 1,206,440,978 | 9999.99% | 0.14% |
| Jan. 15, 2024 | Adaptimmune Therapeutics PLC | $ADAPY | Rawcliffe Adrian | Chief Executive Officer | A | Option to purchase Ordinary Shares | 7633296 | $0.00 | 7,633,296.0000 | 1,206,440,978 | 9999.99% | 0.63% |
| Jan. 17, 2024 | Adaptimmune Therapeutics PLC | $ADAPY | Rawcliffe Adrian | Chief Executive Officer | S | American Depositary Shares representing Ordinary Shares | 30080 | $0.67 | 44,848.0000 | 1,206,440,978 | 40.15% | 0.00% |
| Jan. 16, 2024 | Adaptimmune Therapeutics PLC | $ADAPY | Rawcliffe Adrian | Chief Executive Officer | S | American Depositary Shares representing Ordinary Shares | 9304 | $0.79 | 14,104.0000 | 1,206,440,978 | 39.75% | 0.00% |
| Jan. 12, 2024 | Adaptimmune Therapeutics PLC | $ADAPY | Rawcliffe Adrian | Chief Executive Officer | S | American Depositary Shares representing Ordinary Shares | 17257 | $0.85 | 26,388.0000 | 1,206,440,978 | 39.54% | 0.00% |
| Jan. 11, 2024 | Adaptimmune Therapeutics PLC | $ADAPY | Rawcliffe Adrian | Chief Executive Officer | S | American Depositary Shares representing Ordinary Shares | 11945 | $0.84 | 18,395.0000 | 1,206,440,978 | 39.37% | 0.00% |
| Aug. 7, 2023 | Wave Life Sciences Ltd. | $WVE | Rawcliffe Adrian | Director | A | Share Option (right to buy) | 45000 | $0.00 | 45,000.0000 | 78,855,810 | 9999.99% | 0.06% |